Skip to content
2000
Volume 8, Issue 4
  • ISSN: 2210-3155
  • E-ISSN: 2210-3163

Abstract

Aspergillus is a genus of ubiquitous fungi that are therapeutically important because the genus produces a wide range of structurally diverse secondary metabolites that are of highly considerable interest to both scientific research community and pharmaceutical industry. Genome sequencing results have indicated that chemical diversity of secondary metabolites is much larger in each species than previously thought. This review summarizes a total of 315 new secondary metabolites of Aspergillus reported from 2015 to 2017 and demonstrates the therapeutical potential of this genus by introducing their unique chemical structures and excellent bioactivities from this genus.

Loading

Article metrics loading...

/content/journals/npj/10.2174/2210315508666180501154759
2018-12-01
2025-01-30
Loading full text...

Full text loading...

/content/journals/npj/10.2174/2210315508666180501154759
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test